GCG and metabolic dysfunction-associated steatohepatitis: However, the potential of GLP‐1 RAs to regress fibrosis, as well as to prevent the progression of steatosis to NASH and cirrhosis, is still needed to be confirmed by prospective RCTs with more sensitive end‐points of hepatic fibrosis.